Hemogenyx Pharmaceuticals Statistics
Total Valuation
HOPHF has a market cap or net worth of 10.75 million. The enterprise value is 14.01 million.
| Market Cap | 10.75M |
| Enterprise Value | 14.01M |
Important Dates
The next estimated earnings date is Friday, June 27, 2025.
| Earnings Date | Jun 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 3.35M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +16.95% |
| Shares Change (QoQ) | +15.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 10.06 |
| P/TBV Ratio | 20.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.99 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.69 |
Financial Position
The company has a current ratio of 0.72, with a Debt / Equity ratio of 3.07.
| Current Ratio | 0.72 |
| Quick Ratio | 0.14 |
| Debt / Equity | 3.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.63 |
| Interest Coverage | -19.80 |
Financial Efficiency
Return on equity (ROE) is -309.56% and return on invested capital (ROIC) is -73.03%.
| Return on Equity (ROE) | -309.56% |
| Return on Assets (ROA) | -65.15% |
| Return on Invested Capital (ROIC) | -73.03% |
| Return on Capital Employed (ROCE) | -176.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -439,675 |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.75% in the last 52 weeks. The beta is 0.67, so HOPHF's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -99.75% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 1.24 |
| Relative Strength Index (RSI) | 0.00 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.73M |
| Pretax Income | -7.04M |
| Net Income | -7.03M |
| EBITDA | -6.44M |
| EBIT | -6.73M |
| Earnings Per Share (EPS) | -2.13 |
Balance Sheet
The company has 199,388 in cash and 3.28 million in debt, giving a net cash position of -3.08 million.
| Cash & Cash Equivalents | 199,388 |
| Total Debt | 3.28M |
| Net Cash | -3.08M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.07M |
| Book Value Per Share | 0.32 |
| Working Capital | -400,121 |
Cash Flow
In the last 12 months, operating cash flow was -5.18 million and capital expenditures -16,632, giving a free cash flow of -5.20 million.
| Operating Cash Flow | -5.18M |
| Capital Expenditures | -16,632 |
| Free Cash Flow | -5.20M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HOPHF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.95% |
| Shareholder Yield | n/a |
| Earnings Yield | -65.42% |
| FCF Yield | -48.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |